Dataset Information


Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin.

ABSTRACT: INTRODUCTION:Dysferlin loss-of-function mutations cause muscular dystrophy, accompanied by impaired membrane repair and muscle weakness. Growth promoting strategies including insulin-like growth factor 1 (IGF-1) could provide benefit but may cause strength loss or be ineffective. The objective of this study was to determine whether locally increased IGF-1 promotes functional muscle hypertrophy in dysferlin-null (Dysf-/- ) mice. METHODS:Muscle-specific transgenic expression and postnatal viral delivery of Igf1 were used in Dysf-/- and control mice. Increased IGF-1 levels were confirmed by enzyme-linked immunosorbent assay. Testing for skeletal muscle mass and function was performed in male and female mice. RESULTS:Muscle hypertrophy occurred in response to increased IGF-1 in mice with and without dysferlin. Male mice showed a more robust response compared with females. Increased IGF-1 did not cause loss of force per cross-sectional area in Dysf-/- muscles. DISCUSSION:We conclude that increased local IGF-1 promotes functional hypertrophy when dysferlin is absent and reestablishes IGF-1 as a potential therapeutic for dysferlinopathies.


PROVIDER: S-EPMC6771521 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3804083 | BioStudies
1000-01-01 | S-EPMC5794421 | BioStudies
2015-01-01 | S-EPMC4581601 | BioStudies
2015-01-01 | S-EPMC4445010 | BioStudies
2019-01-01 | S-EPMC6457631 | BioStudies
2012-01-01 | S-EPMC3376115 | BioStudies
2015-01-01 | S-EPMC4450316 | BioStudies
2011-01-01 | S-EPMC3241698 | BioStudies
2011-01-01 | S-EPMC3188867 | BioStudies
2018-01-01 | S-EPMC6066196 | BioStudies